CELZ
Creative Medical Technology Holdings IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$8.06M
P/E Ratio
—
EPS
$-2.07
Beta
1.83
52W High
$6.25
52W Low
$1.50
50-Day MA
$2.22
200-Day MA
$2.52
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Creative Medical Technology Holdings Inc
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company is headquartered in Phoenix, Arizona.
Fundamentals
| Revenue (TTM) | 3,000 |
| Gross Profit (TTM) | 2,006 |
| EBITDA | $-5.82M |
| Operating Margin | -198050.00% |
| Return on Equity | -81.20% |
| Return on Assets | -50.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.65 |
| Price-to-Book | 1.29 |
| Price-to-Sales (TTM) | 2686.25 |
| EV/Revenue | 675.24 |
| EV/EBITDA | -1.46 |
| Quarterly Earnings Growth (YoY) | 358.90% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $3.70M |
| Float | $3.43M |
| % Insiders | 0.95% |
| % Institutions | 6.50% |
Historical Volatility
HV 10-Day
42.76%
HV 20-Day
38.35%
HV 30-Day
41.87%
HV 60-Day
52.08%
HV Rank
7.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($20.00 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026